Tuberculosis Diagnostics Market 2018: Share, Size, Growth Predictions, Trends, Latest Developments, Application and 2024 Forecast

The report defines tuberculosis (TB) diagnosis market as the several tests performed on the specimen taken from the patient to identify the Mycobacterium tuberculosis bacteria in the patient’s body. Mycobacterium tuberculosis bacteria cause the infectious disease known as tuberculosis. The Mycobacterium tuberculosis bacteria can spread into the air by the people are infected with TB through the coughing, sneezing or spitting. These bacteria generally affect the lungs but may affect the other part of the body.

Need Assistance? Send an Enquiry@ https://www.infiniumglobalresearch.com/reports/enquiry/955

Rapidly growing occurrence of TB is the primary factor that drives the growth of TB diagnosis market worldwide. According to WHO, Tuberculosis is one of the top 10 causes of death worldwide and in 2016, 10.4 million people fell ill with TB, and 1.7 million died from the disease (including 0.4 million among people with HIV). TB diagnostics plays important role in the TB treatment. The high prevalence of TB creates a huge demand for TB testing systems. In addition availability of more advanced TB diagnosis methods are contributing in the growth of TB market.

The government organizations are taking initiative to launch new awareness programs to prevent or overcome the Tuberculosis that expected to boost the growth of TB diagnosis market. Furthermore, the introduction of new advanced and easy diagnosis methods such as Interferon-gamma release assay, and cytokine detection assay are contributing in the growth of TB diagnosis market. Additionally, ongoing research and development of new and effective tuberculosis treatment drugs are projected to create several growth opportunities in the TB drugs market.

Market Segmentation by Type

Global TB market on the test type is segregated into, Radiographic Methods, Nucleic Acid Testing, Laboratory Methods, Drug-susceptibility Testing, Mantoux Test (TST) and others. Nucleic Acid Amplification Tests is the Food and Drug Administration (FDA) approved testing used in the TB diagnosis can reliably detect Mycobacterium tuberculosis bacteria in specimens. The testing equipment easily available commercially. In addition, the factors such as new guidelines proposed for the use of NAA tests for TB diagnosis are projected to various opportunities in the Nucleic Acid Testing market. On the other hand, Radiographic Methods is the most ideal method used in the diagnosis of TB. This method required complex and expensive equipment. The yield of radiographic screening is generally low in the radiographic TB diagnosis, generally ranging from 5 cases 9, 10 to 15 cases 11 per 10 000 individuals screened.

Download Exclusive Sample Copy of Report: https://www.infiniumglobalresearch.com/reports/sample-request/955

Regional Analysis

The report of the global TB diagnosis market covers North America, Europe, Asia-Pacific and RoW regions in the scope of the study. Among these regions, Asia Pacific is the largest and the fastest growing region in the TB diagnosis market. India accounts for the largest share of the TB Diagnostic market. According to the TB Report 2017 released by World Health Organization (WHO), India continues to have the highest number of tuberculosis cases in the world. Additionally, Over 95% of TB deaths occur in low- and middle-income countries in such as India, China, Africa and others, that contributes in the growth of Asia Pacific TB market. This creates the massive demand of cost-effective TB testing that drives the growth of Asia Pacific TB diagnostics market.

Competitive Landscape

The key companies profiled in the global TB diagnosis market include Becton, Dickinson and Company, F. Hoffmann-La Roche AG, Thermo Fisher Scientific, Inc., BioMerieux SA, Hain Lifescience GmbH, Hologic Corporation, Abbott Laboratories, Alere, Inc, Siemens, Cepheid and others.

Read Detailed Index of full Research Study @ https://www.infiniumglobalresearch.com/healthcare-medical-devices/global-tuberculosis-diagnostics-market

About Infinium Global Research

Infinium Global Research and Consulting Solutions is started with a single motto of being a business partner of the first choice. We at Infinium work on the strengths of our clients to ensure we help them consolidate their market position. We firmly believe in the fact that ‘if you are able to develop newer opportunities then you find there is no dearth of opportunities for you. With our strategic research approaches and deep dive in the market segments, we try to find out new opportunities that our clients can encash with their existing resources. Our experts with over 100 years of cumulative experience in research offer the best in the industry services to our clients to ensure that they achieve their business goals.

Contact Us:

Infinium Global Research
Office No. 04, 06, Ganadhish Empire,
Rahatani Corner, Pune, MH 411027
Email: info@infiniumglobalresearch.com
Website: www.infiniumglobalresearch.com

This release was published on openPR.